Update on Bausch + Lomb Q2 Performance (1) • Consumer • RX Pharma • Surgical • Contact Lens • Generics Emerging Markets Other Developed Markets Organic Growth: Q2 2014/Q2 2013 22 14% 8% 14% United States 12% 17% 12% 38% 3% Country/Region Notes (1) Total 12% ~90% of growth in the U.S. was from volume Preliminary Estimates >90% of the growth on a global basis was from volume Exhibit 99.2 |
Bausch + Lomb Performance Acquisition through Q2 2014 (1) • Consumer • RX Pharma • Surgical • Contact Lens • Generics Emerging Markets Other Developed Markets Organic Growth since acquisition 23 13% 10% 13% United States 12% 11% 11% 12% 29% Country/Region Notes (1) Total 11% ~90% of growth in the U.S. was from volume Preliminary Estimates >90% of the growth on a global basis was from volume |